Regulators of blood lipids and lipoproteins? PPARδ and AMPK, induced by exercise, are correlated with lipids and lipoproteins in overweight/obese men and women

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 10, 2012, Pages

  Greene, Nicholas P ^a   Fluckey, James D ^a   Lambert, Brad S ^a   Greene, Elizabeth S ^a   Riechman, Steven E ^a   Crouse, Stephen F ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Adenosine 5 monophosphate activated protein kinase; Cholesterol; Mitochondria; Oxidative metabolism; Peroxisome proliferator activated receptor coactivator 1 ; Peroxisome proliferator activated receptor

Indexed keywords

ABC TRANSPORTER A1; ADENOSINE TRIPHOSPHATASE; ADENYLATE KINASE; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; CYCLOOXYGENASE 4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BODY FAT; BODY MASS; CLINICAL ARTICLE; DIETARY INTAKE; ENDURANCE TRAINING; ENERGY EXPENDITURE; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SKELETAL MUSCLE; VENOUS OXYGEN TENSION;

ADENYLATE KINASE; ANTIGENS, CD36; ATP-BINDING CASSETTE TRANSPORTERS; BIOPSY; BLOTTING, WESTERN; CHOLESTEROL; COHORT STUDIES; ENERGY METABOLISM; EXERCISE; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OBESITY; PPAR ALPHA; PPAR DELTA; PROTON-TRANSLOCATING ATPASES; RECEPTORS, LDL; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS;

EID: 84869191684     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00309.2012     Document Type: Article

References (52)

1. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription (7th ed.). Philadelphia, PA: Lippincott Williams & Wilkins, 2006.
2. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, Williams RS, Yan Z. Exercise stimulates PGC-1α transcription in skeletal muscle through activation of the p38 MAPK pathway. J Biol Chem 280: 19587-19593, 2005.
3. Baar K, Wende AR, Jones TE, Marison M, Nolte LA, Chen M, Kelly DP, Holloszy JO. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16: 1879-1886, 2002.
4. Bergstrom J. Muscle electrolytes in man-determined by neutron activation analysis on needle biopsy specimens-study on normal subjects, kidney patients, and patients with chronic diarrhoea. Scand J Clin Lab Invest 14: 1-110, 1962.
5. Blair SN, Haskell WL, Ho P, Paffenbarger RS, Vranizan KM, Farquhar JW, Wood PD. Assessment of habitual physical-activity by a 7-day recall in a community survey and controlled experiments. Am J Epidemiol 122: 794-804, 1985.
6. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 2: 92-98, 1970.
7. Bruce RA, Kusumi F, Hosmer D. Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 85: 546-562, 1973.
8. Buhl ES, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen SB, Pedersen O, Schmitz O, Lund S. Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51: 2199-2206, 2002
9. Cartoni R, Léger B, Hock MB, Praz M, Crettenand A, Pich S, Ziltener JL, Luthi F, Dériaz O, Zorzano A, Gobelet C, Kralli A, Russell AP. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol 567: 349-358, 2005.
10. Centers for Disease Control and Prevention. Centers for for Disease Control and Prevention Behavioral Risk Factor Surveillance System Survey Data Website (Online). http://www.cdc.gov/brfss/index.htm [18 Sept 2009].
11. Clark SA, Chen ZP, Murphy KT, Aughey RJ, McKenna MJ, Kemp BE, Hawley JA. Intensified exercise training does not alter AMPK signaling in human skeletal muscle. Am J Physiol Endocrinol Metab 286: E737-E743, 2004.
12. Dill DB, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 37: 247-248, 1974
13. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17: 2477-2493, 2003.
14. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA 101: 6999-7004, 2004.
15. Dupont-Versteegden EE, Strotman BA, Gurley CM, Gaddy D, Knox M, Fluckey JD, Peterson CA. Nuclear translocation of EndoG at the initiation of disuse muscle atrophy and apoptosis is specific to myonuclei. Am J Physiol Regul Integr Comp Physiol 291: R1730-R1740, 2006.
16. Evans WJ, Phinney SD, Young VR. Suction applied to a muscle biopsy maximizes sample size. Med Sci Sports Exerc 14: 101-102, 1982.
17. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39-48, 2007.
18. Fritz T, Krämer DK, Karlsson HK, Galuska D, Engfeldt P, Zierath JR, Krook A. Low-intensity exercise increases skeletal muscle protein expression of PPARdelta and UCP3 in type 2 diabetic patients. Diabetes Metab Res Rev 22: 492-498, 2006.
19. Gervois P, Fruchart JC, Staels B. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nat Clin Pract Endocrinol Metab 3: 145-156, 2007.
20. Gibala MJ, McGee SL, Garnham AP, Howlett KF, Snow RJ, Hargreaves M. Brief intense interval exercise activates AMPK and p38 MAPK signaling and increases the expression of PGC-1alpha in human skeletal muscle. J Appl Physiol 106: 929-934, 2009.
21. Greene NP, Greene ES, Carbuhn AF, Green JS, Crouse SF. VO2 prediction and cardiorespiratory responses during underwater treadmill exercise. Res Q Exerc Sport 82: 264-273, 2011.
22. Greene NP, Lambert BS, Greene ES, Carbuhn AF, Green JS, Crouse SF. Comparative efficacy of water and land treadmill training for overweight or obese adults. Med Sci Sports Exerc 41: 1808-1815, 2009.
23. Greene NP, Martin SE, Crouse SF. Acute exercise and training alter blood lipid and lipoprotein profiles differently in overweight and obese men and women. Obesity (Silver Spring) 20: 1618-1627, 2012.
24. Han R, Lai R, Ding Q, Wang Z, Luo X, Zhang Y, Cui G, He J, Liu W, Chen Y. Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia 50: 1960-1968, 2007.
25. Holloway GP, Perry CG, Thrush AB, Heigenhauser GJ, Dyck DJ, Bonen A, Spriet LL. PGC-1α's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1α and PGC-1βprotein. Am J Physiol Endocrinol Metab 294: E1060-E1069, 2008
26. Horowitz JF, Leone TC, Feng W, Kelly DP, Klein S. Effect of endurance training on lipid metabolism in women: a potential role for PPARα in the metabolic response to training. Am J Physiol Endocrinol Metab 279: E348-E355, 2000.
27. Jacobs KA, Krauss RM, Fattor JA, Horning MA, Friedlander AL, Bauer TA, Hagobian TA, Wolfel EE, Brooks GA. Endurance training has little effect on active muscle free fatty acid, lipoprotein cholesterol, or triglyceride net balances. Am J Physiol Endocrinol Metab 291: E656-E665, 2006.
28. Kiens B, Lithell H. Lipoprotein metabolism influenced by traininginduced changes in human skeletal muscle. J Clin Invest 83: 558-564, 1989
29. Kleiner S, Nguyen-Tran V, Baré O, Huang X, Spiegelman B, Wu Z. PPAR{delta} agonism activates fatty acid oxidation via PGC-1{alpha} but does not increase mitochondrial gene expression and function. J Biol Chem 284: 18624-18633, 2009.
30. Kramer DK, Al-Khalili L, Guigas B, Leng Y, Garcia-Roves PM, Krook A. Role of AMP kinase and PPAR delta in the regulation of lipid and glucose metabolism in human skeletal muscle. J Biol Chem 282: 19313-19320, 2007.
31. Leick L, Plomgaard P, Grønløkke L, Al-Abaiji F, Wojtaszewski JF, Pilegaard H. Endurance exercise induces mRNA expression of oxidative enzymes in human skeletal muscle late in recovery. Scand J Med Sci Sports 20: 593-599, 2010.
32. Leick L, Wojtaszewski JF, Johansen ST, Kiilerich K, Comes G, Hellsten Y, Hidalgo J, Pilegaard H. PGC-1α is not mandatory for exercise-and training-induced adaptive gene responses in mouse skeletal muscle. Am J Physiol Endocrinol Metab 294: E463-E474, 2008.
33. Luquet S, Gaudel C, Holst D, Lopez-Soriano J, Jehl-Pietri C, Fredenrich A, Grimaldi PA. Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes. Biochim Biophys Acta 1740: 313-317, 2005.
34. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M, Grimaldi PA. Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17: 2299-2301, 2003.
35. Mathai AS, Bonen A, Benton CR, Robinson DL, Graham TE. Rapid exercise-induced changes in PGC-1α mRNA and protein in human skeletal muscle. J Appl Physiol 105: 1098-1105, 2008.
36. Muoio DM, Koves TR. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: implications for metabolic disease. Appl Physiol Nutr Metab 32: 874-883, 2007.
37. Oliver WR Jr, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98: 5306-5311, 2001.
38. Perry CG, Lally J, Holloway GP, Heigenhauser GJ, Bonen A, Spriet LL. Repeated transient mRNA bursts precede increases in transcriptional and mitochondrial proteins during training in human skeletal muscle. J Physiol 588: 4795-4810, 2010.
39. Ritov VB, Menshikova EV, Azuma K, Wood R, Toledo FG, Goodpaster BH, Ruderman NB, Kelley DE. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am J Physiol Endocrinol Metab 298: E49-E58, 2010.
40. Robinson MM, Richards JC, Hickey MS, Moore DR, Phillips SM, Bell C, Miller BF. Acute β-adrenergic stimulation does not alter mitochondrial protein synthesis or markers of mitochondrial biogenesis in adult men. Am J Physiol Regul Integr Comp Physiol 298: R25-R33, 2010.
41. Röckl KS, Hirshman MF, Brandauer J, Fujii N, Witters LA, Goodyear LJ. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 56: 2062-2069, 2007
42. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
43. Spencer-Jones NJ, Ge D, Snieder H, Perks U, Swaminathan R, Spector TD, Carter ND, O'Dell SD. AMP-kinase alpha2 subunit gene PRKAA2 variants are associated with total cholesterol, low-density lipoprotein-cholesterol and high-density lipoprotein-cholesterol in normal women. J Med Genet 43: 936-942, 2006.
44. Sprecher DL, Massien C, Pearce G, Billin AN, Perlstein I, Willson TM, Hassall DG, Ancellin N, Patterson SD, Lobe DC, Johnson TG. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist. Arterioscler Thromb Vasc Biol 27: 359-365, 2007.
45. Sriwijitkamol A, Ivy JL, Christ-Roberts C, DeFronzo RA, Mandarino LJ, Musi N. LKB1-AMPK signaling in muscle from obese insulinresistant Zucker rats and effects of training. Am J Physiol Endocrinol Metab 290: E925-E932, 2006.
46. Sun W, Lee TS, Zhu M, Gu C, Wang Y, Zhu Y, Shyy JY. Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114: 2655-2662, 2006.
47. Takahashi S, Tanaka T, Kodama T, Sakai J. Peroxisome proliferatoractivated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. Pharmacol Res 53: 501-507, 2006.
48. Taylor EB, Lamb JD, Hurst RW, Chesser DG, Ellingson WJ, Greenwood LJ, Porter BB, Herway ST, Winder WW. Endurance training increases skeletal muscle LKB1 and PGC-1α protein abundance: effects of time and intensity. Am J Physiol Endocrinol Metab 289: E960-E968, 2005
49. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2: 1532-1539, 2004.
50. Weise SD, Grandjean PW, Rohack JJ, Womack JW, Crouse SF. Acute changes in blood lipids and enzymes in postmenopausal women after exercise. J Appl Physiol 99: 609-615, 2005.
51. Weyrich P, Machicao F, Staiger H, Simon P, Thamer C, Machann J, Schick F, Guirguis A, Fritsche A, Stefan N, Häring HU. Role of AMP-activated protein kinase gamma 3 genetic variability in glucose and lipid metabolism in non-diabetic whites. Diabetologia 50: 2097-2106, 2007
52. Zandbergen F, Plutzky J. PPARalpha in atherosclerosis and inflammation. Biochim Biophys Acta 1771: 972-982, 2007.